IAC Express 2008 |
Issue number 718: March 17, 2008 |
|
Contents
of this Issue
Select a title to jump to the article. |
- March
2008 issue of Needle Tips offers many resources for childhood, adolescent,
and adult immunization
- CDC
updates its recommendations for administering combination MMRV vaccine
- VIS news:
CDC releases interim VISs for MMR vaccine and varicella vaccine
-
Important: Be sure to give influenza vaccine throughout the influenza
season--from now through spring
- IAC
updates hepatitis B resource for parents and immunization resource for
health professionals
- March
issue of CDC's Immunization Works electronic newsletter now available
online
- For
primary care practitioners: Interactive training program on increasing
adult vaccination rates offers CE credit
- National
Infant Immunization Week scheduled for April 19-26; CDC's online resources
make it easy to promote
- CDC's
Division of Viral Hepatitis announces poster contest
- March 13
issue of IAC's Hep Express electronic newsletter now online
- For
immunization coalitions: 165 coalitions have posted information on
www.izcoalitions.org--is yours one of them?
- MMWR
reports on progress Eastern Mediterranean made in reducing and eliminating
measles mortality during 1997-2007
|
|
Abbreviations |
|
AAFP, American Academy of Family Physicians; AAP,
American Academy of Pediatrics; ACIP, Advisory Committee on Immunization
Practices; AMA, American Medical Association; CDC, Centers for Disease
Control and Prevention; FDA, Food and Drug Administration; IAC, Immunization
Action Coalition; MMWR, Morbidity and Mortality Weekly Report; NCIRD,
National Center for Immunization and Respiratory Diseases; NIVS, National
Influenza Vaccine Summit; VIS, Vaccine Information Statement; VPD,
vaccine-preventable disease; WHO, World Health Organization. |
|
Issue 718: March 17, 2008 |
|
|
1. |
March 2008 issue of Needle Tips offers many resources for childhood,
adolescent, and adult immunization
IAC recently mailed the latest issue of Needle
Tips (March 2008) to 190,000 health professionals and others who work in the
field of immunization. Packed with immunization and hepatitis resources for
health professionals, patients, and parents, the 24-page issue is well worth
downloading. All articles and education pieces, except editorials, have been
reviewed by immunization and hepatitis experts at CDC.
You can view selected articles from the table of contents below or download
the entire issue from the Web.
To download a ready-to-print (PDF) version of the entire issue, go to:
http://www.immunize.org/nslt.d/n38/n38.pdf
The PDF file of the entire issue is large. For tips on downloading and
printing PDF files, go to:
http://www.immunize.org/nslt.d/tips.htm
To view the table of contents with links to individual articles, go to:
http://www.immunize.org/nt
The March issue includes several notable print resources on immunization and
viral hepatitis, all of which can be downloaded:
- Ask the Experts
- Vaccine Highlights
- Hepatitis B Facts: Testing and vaccination
- Hepatitis A and B Vaccines . . . Be sure
your patient gets the correct dose!
- Vaccine Administration Record for Children
and Teens
- Vaccine Administration Record for Adults
- Standing Orders for Administering Vaccines
. . . Free and CDC-reviewed, they're ready for you to download, copy, and
use!
- Recommended Immunization Schedules for
Persons Ages 0-18 Years, U.S., 2008
- Recommended Adult Immunization Schedule
United States, October 2007-September 2008
Back to top |
|
|
2. |
CDC updates its recommendations for administering combination MMRV vaccine
CDC published "Update: Recommendations from the
Advisory
Committee on Immunization Practices (ACIP) Regarding
Administration of Combination MMRV Vaccine" in the March 14
issue of MMWR. Portions of the article are reprinted below.
On February 27, 2008, new information was presented to the
Advisory Committee on Immunization Practices (ACIP) regarding
the risk for febrile seizures among children aged 12-23 months
after administration of the combination measles, mumps, rubella,
and varicella (MMRV) vaccine (ProQuad, Merck & Co., Inc.,
Whitehouse Station, New Jersey). This report summarizes current
knowledge regarding the risk for febrile seizures after MMRV
vaccination and presents updated ACIP recommendations that were
issued after presentation of the new information. These updated
recommendations remove ACIP's previous preference for
administering combination MMRV vaccine over separate injections
of equivalent component vaccines (i.e., measles, mumps, and
rubella [MMR] vaccine and varicella vaccine). . . .
Availability of MMRV vaccine currently is limited in the United
States because of manufacturing constraints unrelated to vaccine
safety or efficacy. MMRV vaccine is not expected to be widely
available before 2009; however, some clinics might have MMRV
vaccine in stock.
Consistent with ACIP General Recommendations on Immunization,
the 2007 ACIP recommendations for prevention of varicella
included a preference for use of combination MMRV vaccine over
separate injections of equivalent component vaccines (i.e., MMR
vaccine and varicella vaccine). At its February 27, 2008,
meeting, ACIP considered the preliminary results from the
Vaccine Safety Datalink (VSD) and Merck studies, which suggested
an increased risk for febrile seizures after the first dose of
MMRV vaccine. Given the availability of alternative options for
vaccination against measles, mumps, rubella, and varicella and
the limited supply of MMRV vaccine, ACIP voted to change the
preference language for MMRV vaccine to read as follows:
"Combination MMRV vaccine is approved for use among healthy
children aged 12 months-12 years. MMRV vaccine is indicated for
simultaneous vaccination against measles, mumps, rubella, and
varicella. ACIP does not express a preference for use of MMRV
vaccine over separate injections of equivalent component
vaccines (i.e., MMR vaccine and varicella vaccine)." ACIP also
recommended establishing a work group to conduct in-depth
evaluation of the findings regarding the increased risk for
febrile seizures after the first dose of MMRV vaccine to present
for consideration of future policy options. CDC, FDA, and ACIP
will communicate updates and implement further necessary actions
based on these evaluations.
Clinically significant adverse events that follow vaccination
should be reported to the Vaccine Adverse Event Reporting System
(VAERS). Guidance about how to obtain and complete a VAERS form
is available at http://www.vaers.hhs.gov or by telephone, (800)
822-7967. Additional information on MMRV vaccine and febrile
seizures is available at
http://www.cdc.gov/od/science/iso/vsd/mmrv.htm and
http://www.fda.gov/cber/label/proquadlbinfo.htm
To access a web-text (HTML) version of the complete article, go
to: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5710a3.htm
To access a ready-to-print (PDF) version of this issue of MMWR,
go to: http://www.cdc.gov/mmwr/PDF/wk/mm5710.pdf
To receive a FREE electronic subscription to MMWR (which
includes new ACIP statements), go to:
http://www.cdc.gov/mmwr/mmwrsubscribe.html
Back to top |
|
|
3. |
VIS news: CDC releases interim VISs for MMR vaccine and varicella vaccine
On March 13, CDC released interim editions of the
VISs for MMR
vaccine and varicella vaccine. The interim VIS for MMR vaccine
replaces the previous edition (dated 1/15/03); the interim VIS
for varicella vaccine replaces the previous edition (dated
1/10/07).
The interim VISs for MMR vaccine and varicella vaccine have been
updated to incorporate information about measles-mumps-rubella-varicella (MMRV) vaccine. This includes information about the
increased rates of certain adverse events such as febrile
seizures after MMRV vaccine administration. (IAC Express
editor's note: See story #2 above for information on changes to
ACIP's recommendations for giving MMRV vaccine.)
When giving MMRV vaccine, the new interim VISs should be used.
When giving MMR vaccine or varicella vaccine separately, the
previously published VISs may be used until stocks are depleted.
To access the interim VIS for MMR vaccine from the CDC website,
go to:
http://www.cdc.gov/vaccines/pubs/vis/downloads/vis-mmr.pdf
To access the interim VIS for MMR vaccine from the IAC website,
go to: http://www.immunize.org/vis/mmr03.pdf
To access the interim VIS for varicella vaccine from the CDC
website, go to:
http://www.cdc.gov/vaccines/pubs/vis/downloads/vis-varicella.pdf
To access the interim VIS for varicella vaccine from the IAC
website, go to: http://www.immunize.org/vis/varic07.pdf
For information about the use of VISs, and for VISs in more than
30 languages, visit IAC's VIS web section at
http://www.immunize.org/vis
Back to top |
|
|
4. |
Important: Be sure to give influenza vaccine throughout the influenza
season--from now through spring
Influenza is currently circulating, and
vaccination should
continue from now until May. Visit the following websites often
to find the information you need to keep vaccinating. Both are
continually updated with the latest resources.
The National Influenza Vaccine Summit website at
http://www.preventinfluenza.org
CDC's Seasonal Flu web section at http://www.cdc.gov/flu
Back to top |
|
|
5. |
IAC updates hepatitis B resource for parents and immunization resource for
health professionals
IAC recently made minor revisions to a
parent-education
resource, "All Kids Need Hepatitis B Shots!" and substantial
revisions to a professional-education resource, "Vaccine
Administration Record for Children and Teens."
To access the revised "All Kids Need Hepatitis B Shots!" go to:
http://www.immunize.org/catg.d/p4055.pdf
To access the revised "Vaccine Administration Record for
Children and Teens," go to:
http://www.immunize.org/catg.d/p2022.pdf
Back to top |
|
|
6. |
March issue of CDC's Immunization Works electronic newsletter now available
online
The March issue of Immunization Works, a monthly
email
newsletter published by CDC, is available on the website of the
National Center for Immunization and Respiratory Diseases
(NCIRD). The newsletter offers members of the immunization
community non-proprietary information about current topics. CDC
encourages its wide dissemination.
The Front Page News article from the March issue is about
National Infant Immunization Week; similar information can be
found in article #8 of this issue of IAC Express. Various other
articles from the March issue of Immunization Works are covered
in this issue or in previous issues of IAC Express. Following is
the text of two articles we have not covered.
OTHER NEWS & SUMMARIES
MAINTAIN CURRENT RECOMMENDATION FOR MCV4: ACIP also voted
against recommending universal vaccination of children 2 years
through 10 years of age with meningococcal conjugate vaccine
(MCV4). This vote maintains the current recommendation to
vaccinate with MCV4 children at high risk 2 through 10 years
old, all children 11 through 18 years old, and adults at high
risk that are 19 years through 55 years old. For persons 2
through 55 years old, MCV4 is preferred; the meningococcal
polysaccharide vaccination (MPSV) is an acceptable alternative
if MCV4 is not available. Adults 56 years old and older at high
risk should receive MPSV.
MEETINGS, CONFERENCES & RESOURCES
NATIONAL INFLUENZA VACCINE SUMMIT: The 2008 National Influenza
Vaccine Summit (NIVS) will be held on May 12-13 in Atlanta, GA.
The National Influenza Vaccine Summit, co-sponsored by the
American Medical Association and the CDC, meets annually to
provide a forum for discussing influenza vaccine issues with
stakeholders from public, private and non-profit organizations.
For more information, please visit The National Influenza
Vaccine Summit Website.
Issues of Immunization Works are posted on CDC's Vaccines &
Immunizations website a few days after publication. To access
the March issue, go to:
http://www.cdc.gov/vaccines/news/newsltrs/imwrks Click on the
link titled "Mar" under the banner titled "2008 Newsletters
Available Online."
Back to top |
|
|
7. |
For primary care practitioners: Interactive training program on increasing
adult vaccination rates offers CE credit
The CDC website recently posted an interactive
training program
for primary care practitioners. "Increasing Adult Vaccination
Rates: WhatWorks" gives each participant the opportunity to work
through a case study in a setting similar to the one the
participant works in. Continuing Education credits are
available.
To learn more about the program, go to:
http://www2.cdc.gov/vaccines/ed/whatworks/index.html
Back to top |
|
|
8. |
National Infant Immunization Week scheduled for April 19-26; CDC's online
resources make it easy to promote
National Infant Immunization Week (NIIW) is an
annual observance
to highlight the importance of protecting infants from vaccine-preventable diseases and celebrate the achievements of
immunization programs and their partners in promoting healthy
communities. Since 1994, NIIW has served as a call to action for
parents, caregivers, and healthcare providers to ensure that
infants are fully immunized against 14 vaccine-preventable
diseases. This year NIIW will be held April 19-26.
During NIIW 2008, hundreds of communities across the United
States will join those in the Western Hemisphere and Europe to
celebrate Vaccination Week in the Americas (VWA) and European
Immunization Week. More than sixty countries around the world
will participate.
Please visit http://www.cdc.gov/vaccines/events/niiw for
additional resources on planning an NIIW event and to download
English and Spanish-language NIIW campaign materials including
print ads, radio public service announcements (PSAs), sample op-ed articles, and other public relations and planning tools. You
can also provide information on your 2008 NIIW activities/event
through this web page.
Back to top |
|
|
9. |
CDC's Division of Viral Hepatitis announces poster contest
[The following is cross posted from IAC's Hep
Express electronic
newsletter, 3/13/08.]
CDC's Division of Viral Hepatitis is sponsoring a national
poster contest in honor of World Hepatitis Day, which will take
place on May 19.
Individual artists of amateur and professional status are
eligible to participate. Organizations who would like to submit
a group entry are also eligible. There are three categories
(General Viral Hepatitis Awareness, Hepatitis B, and Hepatitis
C). Each individual or organization is allowed only one entry
per category. Posters may be computer-generated/enhanced or
handmade in any medium.
Submissions must be received by midnight Friday, April 18, 2008.
A grand prize of $1000 will be awarded to the best poster from
all the contest entries. A $250 prize will be awarded to the top
entry in each category. Winning posters will be featured on
CDC's website, printed, and distributed nationally.
Please tell colleagues, clients, family, and friends about the
contest and encourage them to submit an entry. If your
organization has a website or newsletter, please consider
promoting the contest via these channels.
For official contest rules, or to submit an entry, visit
http://www.cdc.gov/hepatitis/postercontest
Back to top |
|
|
10. |
March 13 issue of IAC's Hep Express electronic newsletter now online
The March 13 issue of Hep Express, an electronic
newsletter
published by IAC, is now available online. It is intended for
health professionals, program planners, and advocates involved
in prevention, screening, and treatment of viral hepatitis.
IAC Express has already covered some of the information
presented in the March 13 Hep Express; titles of articles we
have not yet covered follow.
-
IAC adds information to its hepatitis prevention programs
website
-
Washington State API Hepatitis B Task Force develops new
brochure for pregnant women
-
HCV [hepatitis C virus] infections traced to Nevada endoscopy
clinic
-
HBF [Hepatitis B Foundation] posts Winter 2008 issue of "B
Informed" newsletter on its website
-
HBF offers seven podcasts related to hepatitis B
-
New York State Department of Health sponsoring hepatitis C
conference on March 25
-
North American Syringe Exchange Convention to be held April
30-May 3, in Tacoma, WA
-
Digestive Disease Week to be held May 17-22, in San Diego
-
International Harm Reduction Conference scheduled for May 11-
15, in Barcelona, Spain
-
National Harm Reduction Conference set for November 13-16, in
Miami
To access the March 13 issue, go to:
http://www.hepprograms.org/hepexpress/issue68.asp
To sign up for a free subscription to Hep Express, go to:
http://www.immunize.org/subscribe
To access previous issues of Hep Express, go to:
http://www.hepprograms.org/hepexpress
Back to top |
|
|
11. |
For immunization coalitions: 165 coalitions have posted information on
www.izcoalitions.org--is yours one of them?
Since its 2002 launch date, IAC's
izcoalitions.org website
(http://www.izcoalitions.org) has posted information from 165
immunization coalitions. The site includes data from coalitions
at all levels (local, state, regional, and national) and of all
types, vaccine-specific as well as age-specific (childhood,
adult, senior).
This online database allows health professionals, immunization
advocates, parents, and others to contact specific coalitions to
find resources, share ideas, and form strategic partnerships.
Searches can be done by coalition name or geographic area.
Be sure your coalition is part of this powerful web-based
networking tool by logging on and checking for your coalition's
listing. If your coalition is not listed, sign up today. If
you're already signed up, and information about your coalition
has changed, be sure to update your listing to help us keep
izcoalitions.org current and accurate.
To search the izcoalitions.org website, go to:
http://www.izcoalitions.org
If you have questions or difficulties using the website, send an
email to Janelle at janelle@immunize.org or call her at (651)
647-9009.
Back to top |
|
|
12. |
MMWR reports on progress Eastern Mediterranean made in reducing and
eliminating measles mortality during 1997-2007
CDC published "Progress Toward Measles Mortality
Reduction and
Elimination--Eastern Mediterranean Region, 1997-2007" in the
March 14 issue of MMWR. Portions of a summary made available to
the press are reprinted below.
Countries of the World Health Organization's Eastern
Mediterranean Region (EMR) have adopted in 1997 the goal to
eliminate indigenous measles by 2010. Measles immunization and
surveillance strategies have been developed and implemented to
help achieve that goal, as well as to reduce the measles-associated mortality in the region in accordance with the goal
set by the World Health Assembly in 2005 to achieve a 90 percent
reduction in global measles-associated mortality by 2010
compared to 2000. Despite facing significant challenges
including armed conflicts and civil strife in several countries,
the estimated number of measles-related deaths in the Eastern
Mediterranean Region (EMR) has decreased by more than 75 percent
since 2000. To sustain measles mortality reduction and to
achieve the regional measles elimination goal, all EMR countries
will need to achieve a high coverage with the first dose of
measles vaccine and with the second opportunity for measles
immunization offered either as a routine second dose and/or
provided through supplemental immunization activities (SIAs).
To access a web-text (HTML) version of the article, go to:
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5710a5.htm
To access a ready-to-print (PDF) version of this issue of MMWR,
go to: http://www.cdc.gov/mmwr/PDF/wk/mm5710.pdf
Back to top |
|
|
|